1. Home
  2. HURN vs VCEL Comparison

HURN vs VCEL Comparison

Compare HURN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

HOLD

Current Price

$146.25

Market Cap

2.2B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$34.24

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURN
VCEL
Founded
2002
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
HURN
VCEL
Price
$146.25
$34.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$215.50
$58.50
AVG Volume (30 Days)
465.8K
415.3K
Earning Date
05-27-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
5.84
0.32
Revenue
$1,699,143,000.00
$276,259,000.00
Revenue This Year
$11.74
$20.11
Revenue Next Year
$10.71
$19.40
P/E Ratio
$25.41
$107.28
Revenue Growth
11.65
16.45
52 Week Low
$116.12
$29.24
52 Week High
$186.78
$51.45

Technical Indicators

Market Signals
Indicator
HURN
VCEL
Relative Strength Index (RSI) 48.88 41.22
Support Level $132.80 $34.61
Resistance Level $151.95 $38.48
Average True Range (ATR) 7.13 1.67
MACD 2.85 -0.24
Stochastic Oscillator 88.83 26.20

Price Performance

Historical Comparison
HURN
VCEL

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: